Matt Martin
Private Equity Investor at Pathway Bioventures LLC
Profile
Matt Martin is currently a Venture Partner at Pathway Bioventures LLC.
He previously worked as the Director of Technology & Business Development at Electrochaea LLC from 2010 to 2012.
In 2019, he served as the Vice President at ClostraBio, Inc. From 2020 to 2022, he held the position of Vice President at SmartHealth Catalyzer, Inc. Dr. Martin also worked as an Advisor at The University of Chicago in 2010.
Additionally, he has experience as a Principal at Los Alamos National Laboratory.
Dr. Martin holds an MBA from The University of Chicago Booth School of Business, an undergraduate degree from Goshen College, Inc., and a doctorate from Carnegie Mellon University.
Matt Martin active positions
| Companies | Position | Start |
|---|---|---|
Pathway Bioventures LLC
 Pathway Bioventures LLC Investment ManagersFinance Pathway Bioventures LLC (Pathway Bioventures) is a venture capital firm founded in 2018 by Daniel Jacobs. The firm is headquartered in Chicago, Illinois. | Private Equity Investor | 2020-04-30 |
Former positions of Matt Martin
| Companies | Position | End |
|---|---|---|
| SmartHealth Catalyzer, Inc. | Corporate Officer/Principal | 2022-12-30 |
ClostraBio, Inc.
 ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Corporate Officer/Principal | 2020-02-28 |
Electrochaea LLC
 Electrochaea LLC Alternative Power GenerationUtilities Electrochaea LLC develops technology for converting electricity and carbon dioxide into methane. Its technology enables to store renewable energy from wind and solar and represents a viable solution for utility-scale energy storage, grid balancing and carbon recycling. The company was founded in 2009 and is headquartered in St. Louis, MO. | Director/Board Member | 2012-09-29 |
| The University of Chicago | Consultant / Advisor | 2010-07-30 |
Los Alamos National Laboratory
 Los Alamos National Laboratory Miscellaneous Commercial ServicesCommercial Services Los Alamos National Laboratory operates as a multidisciplinary institution. It offers services in science, engineering, earth science, chemistry, mathematics, physics, and space science. The company was founded in 1943 and is headquartered in Los Alamos, NM. | Corporate Officer/Principal | - |
Training of Matt Martin
| Goshen College, Inc. | Undergraduate Degree |
| Carnegie Mellon University | Doctorate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Electrochaea LLC
Electrochaea LLC Alternative Power GenerationUtilities Electrochaea LLC develops technology for converting electricity and carbon dioxide into methane. Its technology enables to store renewable energy from wind and solar and represents a viable solution for utility-scale energy storage, grid balancing and carbon recycling. The company was founded in 2009 and is headquartered in St. Louis, MO. | Utilities |
Los Alamos National Laboratory
Los Alamos National Laboratory Miscellaneous Commercial ServicesCommercial Services Los Alamos National Laboratory operates as a multidisciplinary institution. It offers services in science, engineering, earth science, chemistry, mathematics, physics, and space science. The company was founded in 1943 and is headquartered in Los Alamos, NM. | Commercial Services |
Pathway Bioventures LLC
Pathway Bioventures LLC Investment ManagersFinance Pathway Bioventures LLC (Pathway Bioventures) is a venture capital firm founded in 2018 by Daniel Jacobs. The firm is headquartered in Chicago, Illinois. | Finance |
| SmartHealth Catalyzer, Inc. | |
ClostraBio, Inc.
ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Health Technology |
- Stock Market
- Insiders
- Matt Martin
